KRT7 and posterior cortical atrophy: In-depth studies on the exact distribution and expression of KRT-7 in primary PCa and in progressing metastatic disease may validate and extend results regarding if KRT7 alone or together with luminal (e.g., AR) or SC surface proteins may serve as a prognostic histopathological or circulating tumor cell marker.